Alimera Sciences
6120 Windward Parkway
Suite 290
Alpharetta
Georgia
30005
United States
Tel: 678-990-5740
Fax: 678-990-5744
Website: http://www.alimerasciences.com/
340 articles about Alimera Sciences
-
Alimera Sciences To Present At Citi 2014 Global Healthcare Conference
2/13/2014
-
Alimera Sciences Snags $37.5 Million Private Placement
1/28/2014
-
Alimera Sciences Ships First ILUVIEN® Orders For U.K. National Health Service Hospitals
1/13/2014
-
Alimera Sciences, pSivida Corp Rocket On FDA Labeling Talks For Eye Drug
12/20/2013
-
U.K.'s National Institute for Clinical Excellence (NICE) Issues Final Guidance Recommending Alimera Sciences' ILUVIEN®
12/2/2013
-
Alimera Sciences Reports Third Quarter 2013 Financial Results
11/12/2013
-
Alimera Sciences to Release Third Quarter 2013 Results and Provide Update on Upcoming FDA Advisory Committee Meeting
10/31/2013
-
Alimera Sciences, pSivida Corp Stocks Plunge After Drug Fails to Win FDA Approval Again
10/18/2013
-
U.K.'s National Institute for Clinical Excellence (NICE) Issues Final Appraisal Determination Recommending Alimera Sciences's ILUVIEN® for Chronic Diabetic Macular Edema
10/1/2013
-
Alimera Sciences Reports Second Quarter 2013 Financial Results
8/13/2013
-
Alimera Sciences to Release Second Quarter Fiscal Year 2013 Financial Results
8/6/2013
-
Alimera Sciences Release: France's Transparency Commission Issues Positive Opinion for Reimbursement of ILUVIEN®
7/25/2013
-
Alimera Sciences Added To Russell 2000®, 3000® And Global Indexes
7/1/2013
-
Alimera Sciences Announces Issuance of a Positive Appraisal Recommendation on ILUVIEN® for Consultation in the United Kingdom
6/14/2013
-
Alimera Sciences Reports First Quarter 2013 Financial Results
5/10/2013
-
Alimera Sciences Secures $20 Million Debt Facility
5/8/2013
-
Alimera Sciences Announces First Patient Treated With Commercially Available ILUVIEN®
5/8/2013
-
Alimera Sciences to Release First Quarter Fiscal Year 2013 Financial Results
5/6/2013
-
Alimera Sciences Announces New PDUFA Date for ILUVIEN®
5/1/2013
-
Alimera Sciences Announces Iluvien® Now Available in U.K.
4/29/2013